August 30th, 2009

Fewer Side Effects with New Weight Loss Drug

A new weight loss drug called HistaleanTM based on betahistine is
believed to quell the cravings for fatty foods, and may have pronounced
beneficial effects among women in particular.

Betahistine blocks the H1 and H3 receptors in the brain, receptors connected to the sense of fullness and craving for fatty products. This drug is safe and used for the treatment of over 100 million people who suffer from dizziness or vertigo.

A clinical trial conducted in the U.S. showed that women who took Histalean for three months managed to lose seven times the weight of women who were following a placebo treatment. What is more important is that none of the participants, males or females, did not complained of any serious side effects.

This is a preview of Fewer Side Effects with New Weight Loss Drug. Read the full post (292 words, estimated 1:10 mins reading time)

Share This

Category Health | No Comments »

January 7th, 2009

The Brain Is a Remote Control for Fat Metabolism

A remote control system for the fat metabolism is located within the
brain, according to researchers at the University of Cincinnati (UC).

The
melanocortin system was previously known to control the central nervous
system (CNS). It plays a key role by receiving hormone signals from the
gut and responding to the sensations of hunger or fullness.

The melanocortin system controls the fat metabolism and how fat is being stored, completely independent to the food intake.

The
researchers studied the melanocortin system in rodents. The findings
showed that fat is metabolized when the melanocortin system has an
increased activity. Fat accumulation may be due to the fact that the
melanocortin system`s activity is reduced.

This is a preview of The Brain Is a Remote Control for Fat Metabolism. Read the full post (260 words, estimated 1:02 mins reading time)

Share This

Category 4934 | No Comments »


Close
E-mail It